NEW YORK (GenomeWeb News) – Seattle-based angel funding group Alliance of Angels said today that medical genomics startup ActX raised $1.9 million in a seed round.
Alliance of Angels led the round. According to the angel investment group, ActX is " focused on making actionable patient genomic information truly useful in everyday medical practice."
ActX was founded in 2012 by Chairman Andrew Ury, a Seattle-area physician and entrepreneur with a background in healthcare IT. He was founder and CEO of Practice Partner, an electronic medical record company, and co-founder of PPrNet, a practice-based research network.
"Within six weeks of engaging, our round was already oversubscribed, plus many of our new investors brought with them a wealth of connections and operating experience that will accelerate our company’s growth," Ury said in a statement.